Skip to content

The effect of combination therapy of human chorionic gonadotropin ampoule (HCG) and Letrozole tablet on spermogram parameters in obese men with idiopathic infertility

The comparison the effect of combination therapy of human chorionic gonadotropin ampoule (HCG) and Letrozole tablet with each methods alone on spermogram parameters in obese men with idiopathic infertility

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100614004181N9
Enrollment
45
Registered
2019-10-18
Start date
2019-10-23
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male idiopathic infertility. Male infertility

Interventions

Intervention 1: Intervention group: Intervention group 1: HCG ampoule at a dose of 5000 units twice weekly and letrozole tablet 2.5 mg daily for 3 months. Intervention 2: Intervention group: Intervent

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Obese men with a body mass index greater than 30 Idiopathic infertility Age 20 to 45 years Men with informed consent

Exclusion criteria

Exclusion criteria: Men with a history of genital surgery Men with a history of infectious disease in the genital system Men with symptoms of urinary or genital infection Men with a history of suspected contact or urethritis symptoms Men with spermatogenesis-damaging drugs such as Sulfasalazine Men with history of tobacco and alcohol or drugs consuming Men with a family history of infertility in first degree relatives Men with testicular atrophy Men with varicocele Men with changes in consistency and size of cord and vasodefran and epididymis Men with abnormalities in hormone or renal and liver tests Obese men with age less than 20-year old Obese men with age more than 45-year old Men without informed consent

Design outcomes

Primary

MeasureTime frame
Sperm indices including sperm volume evaluation, sperm count, motility rate and sperm morphology. Timepoint: One day before treatment and 3 months after treatment. Method of measurement: Spermogram test.

Secondary

MeasureTime frame
Serum levels of testosterone. Timepoint: One day before treatment and 3 months after treatment. Method of measurement: Evaluation of venous blood sample based on laboratory kit.;Serum levels of estradiol. Timepoint: One day before treatment and 3 months after treatment. Method of measurement: Evaluation of venous blood sample based on laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYadollah Ahmadi Asrbadr

Tabriz University of Medical Sciences

yadollahahmadi@gmail.com+98 41 3336 4658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026